RK Pharma Solutions LLC
Records under this name other than the patents RK Pharma Solutions LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 9 of 9 · Back to RK Pharma Solutions LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,260,065 | Storage-stable ready-to-use injectable formulations of thiotepa Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,111,208 | Process for the preparation of safinamide mesylate intermediate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,332,495 | Process for the preparation of Degarelix acetate and Degarelix acetate-mannitol premix Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,215,234 | Process for the purification of methylene blue Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,857,677 | Ready to use injectable formulations of melphalan and processes for preparation thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,654,151 | Storage-stable ready-to-use formulations of tigecycline Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,447,499 | Process for the Preparation of Eribulin Mesylate Intermediate Formerly held Lapsed on the fee record Ended Sep 20, 2026 · High confidence | Lapsed on the fee record | Ended Sep 20, 2026 | High confidence |
| US 11,447,513 | Purification Process of Ferric Carboxymaltose Formerly held Lapsed on the fee record Ended Sep 20, 2026 · High confidence | Lapsed on the fee record | Ended Sep 20, 2026 | High confidence |
| US 11,324,771 | Process for the preparation of hydroxocobalamin hydrochloride Formerly held Lapsed on the fee record Ended May 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2026 | From the USPTO record |